NSABP Foundation

The NSABP Foundation is a nonprofit organization with a history of conducting ground-breaking clinical trial research in breast and colorectal cancer.

[NSABP Foundation @NSABPFoundation]

June is #CancerSurvivorsMonth. We celebrate the strength, resilience & determination of cancer survivors everywhere. Their experiences inspire hope, drive progress & remind us why advancing cancer research matters. To all survivors: we honor your journey.💜#ClinicalTrials

[NRG Oncology @NRGonc]

Premenopausal pts w/ER+/HER2- #breastcancer who remain at high risk for recurrence may benefit from intensified systemic therapy strategies. Yesterday at #ASCO26, Dr. Mamounas discussed NRG-BR009 OFSET, a study evaluating the addition of chemotherapy to OFS + endocrine therapy.

[Thomas George, MD, FACP, FASCO @TGeorgeMD]

Pretty much all you need to know today. We just scienced a new treatment for pancreatic cancer. 💥

#ASCO26
#CancerResearch
#ClinicalTrial

[NRG Oncology @NRGonc]

Tomorrow at #ASCO26, Dr. Rastogi discusses legacy NSABP B-28 study during a poster session. B-28 was a randomized trial comparing the worth of paclitaxel following doxorubicin/ cyclophosphamide in patients with #breastcancer and who had positive axillary nodes. @NSABPFoundation

[NRG Oncology @NRGonc]

Start off your #ASCO26 Monday morning with two NRG Oncology #GynecologicCancer trials highlighted during poster sessions↪️NRG-GY036 with Dr. Ying Liu @YingLiu88 and NRG-GY037 with Dr. Jyoti Mayadev.
@MSKCancerCenter @UCSDHealth

[NSABP Foundation @NSABPFoundation]

Surrounded by some of the brightest minds and strongest leaders in oncology at #ASCO26, our NSABP team is proud to be a part of the meaningful progress in cancer research.

[NSABP Foundation @NSABPFoundation]

The NSABP FC-13 poster will be presented today by @AnwaarSaeed3 at #ASCO26. The FC-13 trial is studying cemiplimab monotherapy or cemiplimab-based combos in pts with #colorectalcancer & MRD after definitive therapy. J Clin Oncol 44, 2026 (suppl 16; abstr TPS3685)

[NRG Oncology @NRGonc]

From groundbreaking science to practice-changing clinical research, NRG Oncology is proud to have a strong presence at #ASCO26. Take a look at the impactful NRG Oncology research being presented at #ASCO26. #CancerResearch #ClinicalTrials #Oncology

[NRG Oncology @NRGonc]

Want a preview of the NRG Oncology research being presented next week at #ASCO26? Take a look at our flyer ➡️https://t.co/McxTfBJrRb

[RTOG Foundation @RTOGFoundation]

Have communications experience and want to learn more about RTOG? We are now accepting applications for our July 2026- July 2027 RTOG Foundation Communications Interns. More details: https://t.co/v7G0YX1jnr Applications due JUNE 10TH

[NRG Oncology @NRGonc]

Don't miss these upcoming podcast episodes on results presented during #ASCO26. Topics: Updated OS analysis of NRG-GY018 w/ @rne_md & the a combined analysis of prostate cancer studies w/ @krishnan_patel & @APDicker: https://t.co/PPnktscHlO

[NSABP Foundation @NSABPFoundation]

The NSABP Foundation Operations Office and Pathology are closed today, May 25, 2026 in observance of the Memorial Day holiday. Regular business hours resume tomorrow.

[NRG Oncology @NRGonc]

Join us in Denver for #NRG2026 Summer Meeting! Featuring scientific sessions, early-career education, networking, expanded symposium & more! Register by June 23 to avoid late fee! https://t.co/uVKfeBQgvU

[NSABP Foundation @NSABPFoundation]

Attending #ASCO26? The NSABP FC-13 poster will be presented by @AnwaarSaeed3 on May 30th. The FC-13 trial is studying cemiplimab monotherapy or cemiplimab-based combos in pts with #colorectalcancer & MRD after definitive therapy. J Clin Oncol 44, 2026 (suppl 16; abstr TPS3685)

[NSABP Foundation @NSABPFoundation]

Behind every advance in cancer care is a #clinicaltrial made possible by patients, caregivers & clinical research teams working together. On #ClinicalTrialsDay, we celebrate collaboration, dedication & innovation driving progress for patients everywhere. #CTD2026 #ResearchRising

[NSABP Foundation @NSABPFoundation]

The OFSET study is evaluating whether adding chemotherapy to ovarian function suppression + endocrine therapy can improve outcomes compared to standard hormonal treatment alone for premenopausal patients with high-risk ER-positive/HER2-negative #breastcancer. Learn more⤵️

[NRG Oncology @NRGonc]

The NRG-BR009 OFSET #clinicaltrial is evaluating whether adding chemo to ovarian suppression + endocrine therapy improves outcomes in patients with high-risk ER+/HER2- premenopausal #breastcancer. Clinical trial participation is vital. Learn more➡️ https://t.co/uBsp6vbUK7

[NSABP Foundation @NSABPFoundation]

#Clinicaltrialresearch is vital. "Every new medicine and treatment started with volunteers participating in clinical trials." You can support the work of the NSABP Foundation today: https://t.co/8UUHriPx0O #NSABPFoundation #CancerResearch

[NSABP Foundation @NSABPFoundation]

National Nurses Week 2026 is May 6-12. The week-long celebration always starts on May 6 #NationalNursesDay and ends on May 12, honoring the birthday of Florence Nightingale. The 2026 theme from ANA is "The Power of Nurses" #ThankANurse

[NSABP Foundation @NSABPFoundation]

Since inception in 1957, the NSABP Foundation has designed and led numerous clinical trials pioneering new standards for treating breast and colorectal cancer. https://t.co/G7DCb7cjSS

[NRG Oncology @NRGonc]

May is #BrainCancerAwarenessMonth. The NRG-CC017 trial builds on early data suggesting TMPRT may extend survival while preserving memory & cognitive function. This phase III study will test its benefit in a large, randomized setting. Learn more➡️ https://t.co/sZEWFnfXga